DataKnowledgeCloudtrainingcoordination

L1000 LINCS DCIC REP.B003 HA1E 24H L21 adoprazine 0.25uM.tsv.gz (File)

Taxon:

Homo sapiens

Taxon (Entity type)

Subject:

HA1E

Subject (Entity type)

Project:

LINCS-2021

Project (Entity type)

File Format:

TSV

File Format (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Data Type:

gene expression profile

Data Type (Entity type)

Compression Format:

GZIP format

File Format (Entity type)

Biosample:

L1000 LINCS DCIC 2021 REP.B003 HA1E 24H L21 adoprazine 0.25uM

Biosample (Entity type)

Assay Type:

landmark transcript profiling assay

Assay Type (Entity type)

Anatomy:

kidney

Anatomy (Entity type)

Uncompressed Size In Bytes:362 KB

Size In Bytes:167 KB

Sha256:be9c04efbf585aae74ededf4498074ab6e5ee90afcee99e0e964939f16200638

Persistent Id:drs://drs.lincs-dcic.org/7bee6a4771f0908d50416e051f50a791

Mime Type:application/gzip

Md5:7bee6a4771f0908d50416e051f50a791

Filename:L1000_LINCS_DCIC_REP.B003_HA1E_24H_L21_adoprazine_0.25uM.tsv.gz

Creation Time:2021-01-21T00:00:00

Access Url:

drs://drs.lincs-dcic.org/7bee6a4771f0908d50416e051f50a791

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 REP.B003 HA1E 24H L21 adoprazine 0.25uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 REP.B003 HA1E 24H L21 adoprazine 0.25uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.